THE BASIC PRINCIPLES OF MBL77

Not all sufferers with CLL demand therapy. Regardless of all new advances, the iwCLL however recommends watchful observation for patients with asymptomatic disorder.86 This suggestion is based on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104